Looking at the broadest combined results, people who started a GLP-1 medication were less likely to develop any substance use disorder over the next 3 years compared to the people who started the comparison diabetes medication
Our experienced medical team is equipped to assess and address B12 deficiencies for a variety of clients, including those with: Pernicious Anemia : A condition where the body cannot make enough intrinsic factor, a protein needed to absorb B12 in the gut
When combined with the reduced food intake associated with GLP-1 therapy, monitoring nutritional status may be appropriate in some cases
While this was not a head-to-head trial, the time-adjusted comparison is notable
You will receive instructions on how to use it, along with guidance on dosing and consistency
Holt, GLP-1-based diabetes therapies